We speak with a member of BioProcess International's editorial advisory board about the link between friendship and business.

But before we say goodbye to 2025, we leave you with five of our favorite features from this year, delving deeper into a few ...

A new clinical trial has shown promising safety and efficacy results for liraglutide in the treatment of Alzheimer’s disease.

Biotechnology company Leucid Bio announced a strategic collaboration with Syenex, an open-source gene therapy platform firm.

The company is struggling to make ends meet as it loses a major undisclosed client.

The 13 partners hope their research into establishing a universal test can help save time and money for therapy developers.

Large pharmaceutical conglomerate Eli Lilly has announced plans to build a $6 billion manufacturing facility in Huntsville, Alabama. The site will focus on the production of small molecules and ...

Because of NextCell’s algorithm that allows optimized donor choice for MSC production, its therapy could be completely ...

Learn about the basics of single-use venting and gas filtration, how to tackle common pain points, and see the PureFlo® PE ...

Explore the latest news and expert commentary by Quentin Leclerc, brought to you by the Contributor of BioProcess International.

The PrIMAVeRa project develops a platform to evaluate how mAbs can combat AMR by reducing antibiotic use and providing ...

As AI reshapes biotechnology, stakeholders are acting to establish governance to maintain safety and efficacy standards.